Vor Biopharma Inc. · NASDAQ:VOR
Verve Capital Limited reported a 9.90% stake in Vor Biopharma Inc. (Schedule 13G)
Event Sep 18, 2025 · Filed Sep 26, 2025
Verve Capital Limited reported a 9.90% stake in Vor Biopharma Inc., 760,699 shares, as a passive investor on Sep 18, 2025. Filed Sep 26, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 760,699
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Verve Capital Limited | 9.90% | 760,699 |
Source
Related
- Vor Biopharma Inc.
- Verve Capital Limited
- Vor Biopharma Inc. shareholders
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026
- Schedule 13G/A · Verve Capital Limited · May 15, 2026
- Schedule 13G/A · Verve Capital Limited · Feb 17, 2026
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2026